The Net Margin of Polus BioPharm Inc (007630.KS) is -66.65%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
| Date | Value |
|---|---|
| 2020-12-31 | -66.65% |
| 2019-12-31 | -139.80% |
| 2018-12-31 | -239.62% |
| 2017-12-31 | -10.02% |
| 2016-12-31 | -54.70% |
| 2015-12-31 | -22.43% |
| 2014-12-31 | 1.95% |
| 2013-12-31 | -24.61% |
| 2012-12-31 | 1.09% |
| 2011-12-31 | -17.80% |